gip/glp-1 receptor agonist drugs The Sustained Effects of a Dual Agonist, NNC0090-2746, in Patients with Type 2 Diabetes The dual glucose-dependent insulinotropic polypeptide
Pay in 4 interest-free payments of $6.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28



























